• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

NAACOS Submits Comments to CMS Regarding International Pricing Index Model

Article

The National Association of Accountable Care Organizations (NAACOS) has submitted commented to CMS in response to the proposed International Pricing Index Model for Medicare Part B Drugs.

The National Association of Accountable Care Organizations (NAACOS) has submitted commented to CMS in response to the proposed International Pricing Index Model for Medicare Part B Drugs. Writing to CMS Administrator Seema Verma, the association said they appreciate CMS' efforts to lower drug prices as Medicare Part B drug spending has increased approximately 10% each year since 2011.

However, they also write that the proposal includes a number of unanswered questions about how the proposed model affects ACOs, which must be addressed before moving forward. They include recommendations on how CMS can address Part B drug costs while working with the Medicare Shared Savings Program and other ACO programs. Read the full comments and recommendations.

Related Videos
Dr Debra Patt
ASCO GI 2026 Recap
Dr Debra Patt
Michael David Chuong, MD, radiation oncologist, Miami Cancer Institute, Baptist Health South Florida
Yuman Fong, MD, cancer surgeon, City of Hope
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, assistant professor in the department of integrative translational sciences at City of Hope
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Debra Patt
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.